跳至主要内容
临床试验/ISRCTN97241637
ISRCTN97241637已完成未知

An evaluation of the effectiveness of ibuprofen and morphine for acute pain in sickle cell disease: a double-blind, placebo-controlled randomised trial

orth West London Hospitals NHS Trust (UK)0 个研究点目标入组 320 人开始时间: 2009年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adult patients with SCD of any phenotype and gender aged 16 years and over.

排除标准

  • 1. Patient has a history of allergic reaction to either morphine or ibuprofen
  • 2. Patient has contraindications to morphine or ibuprofen, e.g. peptic ulcer disease, non-steroidal anti-inflammatory drug (NSAID)-induced asthma
  • 3. Patient in a drug dependency programme
  • 4. Patient is on renal dialysis
  • 5. Stroke within the last 6 weeks
  • 6. Platelet count less than 50 x 10^9/l
  • 7. Patient is pregnant or breastfeeding
  • 8. Doctor unwilling to randomise the patient for other reasons
  • 9. Previous participation in the trial

研究者

发起方
orth West London Hospitals NHS Trust (UK)

相似试验

Ibuprofen and morphine for acute pain in sickle cell... | 临床试验